Atrial Fibrillation: Treatment

Answers to all your questions about AF here

Atrial Fibrillation: Treatment

Atrial fibrillation (AF) requires a comprehensive treatment approach to prevent serious complications such as stroke and the heart failure. AF treatment focuses on controlling heart rhythm and the heart rate, preventing clot formation and addressing the underlying causes.

1. Lifestyle Changes and Risk Factor Management

Lifestyle changes and risk factor management are fundamental to the long-term treatment of atrial fibrillation. It is up to the patient to make them and they should be insisted on, since no treatment will be very effective if risk factors are not controlled:

Weight Control:

Obesity is a significant risk factor for AF. Losing weight and maintaining a healthy weight can reduce the frequency and severity of AF episodes.

Regular Physical Activity:

Regular moderate exercise can help improve overall cardiovascular health and reduce AF episodes. However, it is important to avoid strenuous exercise that could trigger arrhythmias.

Reducing Alcohol and Caffeine Intake:

These substances can trigger AF episodes in some people, so their intake should be limited.

Controlling cardiovascular risk factors:

Controlling blood pressure, diabetes mellitus, smoking, dyslipidaemia… is necessary to increase the chances of successful treatment.

2. Rhythm and Heart Rate Control

Treatment of atrial fibrillation usually starts with managing heart rhythm and rate. This can be done in two ways:

Rhythm Control:

The aim is to restore and maintain normal heart rhythm (sinus rhythm). This can be achieved with antiarrhythmic drugs (amiodarone, sotalol, flecainide… ). In some cases, electrical cardioversion may be considered, a procedure in which a controlled electric shock is delivered to restore sinus rhythm.

Rate Control:

Instead of restoring sinus rhythm, it is accepted that the patient will remain in atrial fibrillation permanently. The aim is to control the rate or speed at which the heart beats. This is achieved with drugs such as beta-blockers, calcium channel blockers (verapamil, diltiazem) or digoxin. This approach suits many patients and can help relieve AF symptoms.

3. Invasive Procedures

When medication is not enough to control atrial fibrillation or when symptoms are severe, invasive procedures can be considered:

Atrioventricular node ablation and pacemaker implantation:

When the heart rate in atrial fibrillation cannot be controlled with medical treatment, atrioventricular node ablation with pacemaker implantation can be considered. Ablating the AV node electrically isolates the atria from the ventricles. This is defined as atrioventricular block, and what happens is that the heart's electrical system below the AV node (the His-Purkinje system) starts producing beats (at a low rate, because the His-Purkinje escape is slow). That is why a pacemaker must be implanted in the ventricle to deliver impulses at a normal heart rate.

Catheter ablation of the pulmonary veins:

This procedure is used to destroy small areas of heart tissue that are causing atrial fibrillation. It is especially indicated in patients with paroxysmal/persistent AF and in those who do not respond well to medication. Options include cryoablation, radiofrequency ablation and pulsed field ablation.

Maze surgery:

This is a more invasive surgical procedure (it requires a sternotomy) that creates scars in the atria to interrupt the abnormal electrical circuits causing AF. It is generally considered when other treatments have failed.

Fibrilación Auricular: TratamientoAblación venas pulmonares
Pulmonary vein ablation. Atrial fibrillation treatment

4. Stroke Prevention: Anticoagulation

One of the main concerns in treating atrial fibrillation is preventing clot formation, which can lead to a stroke. Anticoagulation is a crucial part of treatment:

Direct Oral Anticoagulants (DOACs):

These include drugs such as apixaban, dabigatran, rivaroxaban and edoxaban. They do not require regular INR monitoring and have a lower risk of bleeding complications than warfarin.

Warfarin:

Although its use has fallen since DOACs were introduced, it remains an option for certain patients, especially those with mechanical heart valves, significant mitral stenosis or severe kidney failure.

The choice of anticoagulant is based on an assessment of stroke risk (using the CHA2DS2-VASc score) and bleeding risk (using the HAS-BLED score).

Test yourself: atrial fibrillation quiz (2024)37 questions with explanations · free
Start the test

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *